Upside, Downside Movers in the Morning
Upside:
-SNOW +24% (earnings, guidance)
-CHPT +19% (earnings, guidance)
-HCM +13% (announces Licensing Agreement with GSK for KRAS-EGFR-Antibody Conjugate Cancer Therapy)
-DLTH +11% (earnings, guidance)
-AVAV +6.3% (Trump Administration places large tariffs on foreign-made drones; receives $465M US Army laser contract award)
-FIVE +6.2% (earnings, guidance)
-SMMT +5.9% (reports Phase III OS benefit for ivonescimab in PD-L1-positive locally advanced or metastatic NSCLC)
-CLYM +5.7% (reports Phase 1 data for CLYM116 in IgA nephropathy)
-PFG +5.7% (Samsung’s insurance units seek to acquire Canopius, PFG stakes in $6.6B deals)
-DPRO +5.1% (Trump Administration places large tariffs on foreign-made drones)
-NVST +2.3% (JPMorgan Chase and Co Raised NVST to Overweight from Neutral, price target: $32 from $29)
Downside:
-RARE -47% (missed primary and secondary endpoints in Phase 3 Aspire data for apazunersen in Angelman syndrome)
-VSXY -18% (earnings, guidance)
-APVO -15% (provides leukemia drug study data update)
-PLRZ -12% (prices 333,333-unit registered direct offering and concurrent PIPE for $4.0M gross at $12.00/shr)
-PSNY -11% (earnings, guidance)
-CPB -6.4% (earnings, guidance)
-FLNC -6.2% (Barclays Cuts FLNC to Underweight from Equal Weight, price target: $10)
-HPE -4.0% (earnings, guidance)
-AVGO -3.1% (earnings, guidance)
-MRNA -2.5% (hearing Rothschild & Co Redburn Cuts MRNA to Sell from Neutral, price target: $81)
-AI -2.1% (earnings, guidance)
Positions: None.
